Registry documenting left atrial appendage closure procedures in Austria
Austrian Left Atrial Appendage Closure Registry
Medical University of Graz · NCT03409159
This study is collecting information on patients with atrial fibrillation in Austria who have had a left atrial appendage closure procedure because they can't take blood thinners, to see how safe and effective the treatment is.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Graz (other) |
| Locations | 1 site (Graz) |
| Trial ID | NCT03409159 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect and document data on patients who have undergone left atrial appendage closure (LAAC) procedures in Austria. It focuses on individuals with atrial fibrillation who are unable to take oral anticoagulation due to contraindications. The observational nature of the study allows for the gathering of real-world evidence regarding the safety and effectiveness of LAAC in this patient population. By tracking outcomes and procedural details, the registry seeks to enhance understanding and improve future treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients in Austria who have received left atrial appendage closure procedures.
Not a fit: Patients who have not undergone LAAC or those who do not provide informed consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights that improve the management and outcomes of patients with atrial fibrillation who cannot use anticoagulants.
How similar studies have performed: While observational registries are common, this specific approach to documenting LAAC procedures in Austria is relatively novel and may provide unique insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who received LAAC in Austria Exclusion Criteria: * Absence of informed consent
Where this trial is running
Graz
- Medical University of Graz — Graz, Austria (RECRUITING)
Study contacts
- Study coordinator: Daniel Scherr, Assoc.Prof. PD Dr.
- Email: daniel.scherr@medunigraz.at
- Phone: +4331638512544
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Atrial Fibrillation, Left Atrial Appendage Closure